Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
11,499,663
-
Share change
-
-661,607
-
Total reported value
-
$616,813,180
-
Put/Call ratio
-
117%
-
Price per share
-
$53.65
-
Number of holders
-
159
-
Value change
-
-$31,454,369
-
Number of buys
-
66
-
Number of sells
-
79
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q2 2016
As of 30 Jun 2016 Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) had 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,499,663 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, THOMPSON SIEGEL & WALMSLEY LLC, BTIM Corp., HealthInvest Partners AB, BlackRock Institutional Trust Company, N.A., AMI ASSET MANAGEMENT CORP, and KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC.
This table shows 159 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.